Sheldon Krimsky | Academic Influence

Sheldon Krimsky's AcademicInfluence.com Rankings

Sheldon Krimsky

Philosophy

#3150

World Rank

#5155

Historical Rank

#1027

USA Rank

Environmental Ethics

#9

World Rank

#11

Historical Rank

#4

USA Rank

Bioethics

#30

World Rank

#30

Historical Rank

#15

USA Rank

Ethics

#278

World Rank

#328

Historical Rank

#105

USA Rank

philosophy Degrees

Download Badge

Philosophy

Sheldon Krimsky's Degrees

Bachelors Philosophy Brooklyn College

Similar Degrees You Can Earn

Best Online Bachelor's in Philosophy 2024

Why Is Sheldon Krimsky Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sheldon Krimsky was a professor of Urban and Environmental Policy and Planning at Tufts University, and adjunct professor in the Department of Family Medicine and Community Health at Tufts University School of Medicine. He was a fellow of the Hastings Center, an independent bioethics research institution.

(See a Problem?)

Sheldon Krimsky's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Social Theories of Risk (1992) (848)
Science in the private interest: has the lure of profits corrupted biomedical research? (2006) (454)
University, Inc: The Corporate Corruption of Higher Education (2005) (376)
Environmental Hazards: Communicating Risks as a Social Process (1988) (253)
Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry (2006) (217)
Conflict of interest policies in science and medical journals: Editorial practices and author disclosures (2001) (177)
Genetic Alchemy: The Social History of the Recombinant DNA Controversy (1984) (173)
A Comparison of DSM-IV and DSM-5 Panel Members' Financial Associations with Industry: A Pernicious Problem Persists (2012) (168)
Biotechnics and Society: The Rise of Industrial Genetics, Sheldon Krimsky. 1991. Greenwood Press, Inc., Westport, CT. 280 pages. ISBN: 0-275-93860-3. $17.95 (1994) (119)
Evaluating risk communication: narrative vs. technical presentations of information about radon. (1992) (109)
Academic-Corporate Ties in Biotechnology: A Quantitative Study (1991) (107)
Conflicts of Interest and Disclosure in the American Psychiatric Association’s Clinical Practice Guidelines (2009) (105)
The weight of scientific evidence in policy and law. (2005) (101)
Agricultural Biotechnology and the Environment: Science, Policy, and Social Issues (1996) (100)
Scientific Journals and Their Authors’ Financial Interests: A Pilot Study (1998) (100)
Financial interest and its disclosure in scientific publications. (1998) (90)
Risk communication in the internet age: The rise of disorganized skepticism (2007) (83)
Do Financial Conflicts of Interest Bias Research? (2013) (73)
Agricultural biotechnology and the environment (1993) (68)
Who Owns Academic Work? Battling for Control of Intellectual Property (2002) (58)
Conflict of interest and cost-effectiveness analysis. (1999) (53)
Technocapitalism: A Critical Perspective on Technological Innovation and Corporatism (2010) (49)
The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act (2017) (49)
Genetic Justice: DNA Data Banks, Criminal Investigations, and Civil Liberties (2010) (46)
Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. (2013) (45)
Field Testing Transgenic PlantsAn analysis of the US Department of Agriculture's environmental assessments (1992) (43)
The P rofit of S cientific D iscovery and Its Normative Implications (1999) (42)
Ten ways in which He Jiankui violated ethics (2019) (42)
The Greatest Experiment Ever Performed on Women: Exploding the Estrogen Myth (2003) (40)
EPISTEMIC CONSIDERATIONS ON THE VALUE OF FOLK-WISDOM IN SCIENCE AND TECHNOLOGY (1984) (38)
THE FUNDING EFFECT IN SCIENCE AND ITS IMPLICATIONS FOR THE JUDICIARY (2005) (38)
An Illusory Consensus behind GMO Health Assessment (2015) (36)
Race and the genetic revolution : science, myth, and culture (2011) (36)
Beyond Technocracy: New Routes for Citizen Involvement in Social Risk Assessment (1982) (33)
Advice Without Dissent (2002) (31)
From Asilomar to industrial biotechnology: Risks, reductionism and regulation (2005) (31)
Combatting the Funding Effect in Science: What’s Beyond Transparency? (2010) (29)
When conflict-of-interest is a factor in scientific misconduct. (2007) (28)
An Epistemological Inquiry into the Endocrine Disruptor Thesis (2001) (28)
Developing unbiased diagnostic and treatment guidelines in psychiatry. (2009) (28)
Commentary: Fraudulent Human Embryonic Stem Cell Research in South Korea: Lessons Learned (2006) (28)
Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5 (2014) (26)
Rights and Liberties in the Biotech Age: Why We Need a Genetic Bill of Rights (2005) (26)
1. A Short History of the Race Concept (2011) (26)
Journal Policies on Conflict of Interest: If this Is the Therapy, What’s the Disease? (2001) (25)
Autonomy, disinterest, and entrepreneurial science (2006) (24)
Roundup litigation discovery documents: implications for public health and journal ethics (2018) (19)
Regulatory Oversight of Genetically Engineered Microorganisms: Has Regulation Inhibited Innovation? (1997) (19)
Time for DNA disclosure. (2009) (17)
Rescuing Science from Politics: Publication Bias, Data Ownership, and the Funding Effect in Science: Threats to the Integrity of Biomedical Research (2006) (16)
Standardized Microcosms in Microbial Risk AssessmentUses and limitations of microcosms for prerelease risk assessment of genetically engineered soilborne bacteria (1995) (15)
Conflicts of interest among committee members in the National Academies’ genetically engineered crop study (2017) (15)
Genetic Explanations: Sense and Nonsense (2013) (14)
Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression (2017) (14)
4. The Ethical and Legal Foundations of Scientific ‘Conflict of Interest’ (2006) (13)
The short life of a race drug (2012) (13)
Managing for the environment (1997) (12)
A conflict of interest. (2003) (12)
Can DNA ‘Witness’ Race?: Forensic Uses of an Imperfect Ancestry Testing Technology (2011) (11)
Small Gifts, Conflicts of Interest, and the Zero-Tolerance Threshold in Medicine (2003) (11)
Implicit precaution, scientific inference, and indirect evidence: the basis for the US Environmental Protection Agency's regulation of genetically modified crops (2003) (11)
Scientific Journals and their Authors’ Financial Interests (1999) (11)
Human gene therapy: must we know where to stop before we start? (1990) (10)
Research under Community Standards: Three Case Studies (1986) (10)
The Arrested Development of Golden Rice: The Scientific and Social Challenges of a Transgenic Biofortified Crop (2016) (10)
Testing pesticides in humans: of mice and men divided by ten. (2007) (9)
Recombinant DNA research: the scope and limits of regulation. (1979) (9)
8. Evolutionary Versus Racial Medicine Why It Matters (2011) (9)
From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development. (2014) (9)
Correcting the scholarly record for research integrity: In the aftermath of plagiarism (2019) (9)
The use and misuse of critical Gedankenexperimente (1973) (8)
Using Dialogues to Explore Genetics, Ancestry, and Race (2017) (7)
The ties that bind or benefit (1980) (7)
Recombinant DNA research: a debate on the benefits and risks. (1977) (7)
Risk assessment and regulation of bioengineered food products (2000) (7)
An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices (2009) (7)
Introduction to special issue of Accountability in Research on conflict of interest in science. (2004) (6)
Endocrine disruptors--a controversy in science and policy: session III summary and research needs. (2001) (6)
The Corporate Capture of Academic Science and Its Social Costs (1985) (6)
GMOs Decoded (2019) (5)
All aboard the biotech express (1998) (5)
Breaking the germline barrier in a moral vacuum (2019) (5)
Report on Reports: Biotechnology Safety: Enabling the Safe Use of Biotechnology: Principles and Practice and Appropriate Oversight for Plants with Inherited Traits for Resistance to Pests (1997) (4)
If the “Physician Payments Sunshine Act” Is a Solution, What Is the Problem? (2017) (4)
Social Responsibility in an Age of Synthetic Biology (1982) (4)
Stem Cell Dialogues: A Philosophical and Scientific Inquiry Into Medical Frontiers (2015) (4)
The Dilemma in Regulating Drug Advertising: Propositional Versus Nonpropositional Content (2013) (4)
Hormone Disruptors A Clue to Understanding the Environmental Cause of Disease (2001) (4)
China's gene therapy drug: do Shenzen SiBiono Gen-Tech's claims hold up? (2005) (4)
Clinical Research Involving Pregnant Women (2017) (4)
Emergence of a scientific and commercial research and development infrastructure for human gene therapy. (2005) (4)
Biotechnology at the Dinner Table: FDA's Oversight of Transgenic Food (2002) (4)
Can Glyphosate-Based Herbicides Contribute to Sustainable Agriculture? (2021) (4)
Environmental Impacts of the Releases of Genetically Modified Organisms (2002) (3)
Genetic Alchemy: The Social History of Recombinant DNA Controversy (1983) (3)
The Moral Choices on CRISPR Babies (2019) (3)
Book Review: Between the Lines (1987) (3)
Sugar Industry Science and Heart Disease (2017) (3)
The Temptations of Corporate Funding. (2004) (3)
DNA Dragnets and Race : Larger Social Context , History and Future (2008) (3)
A Citizen Court in the Recombinant DNA debate. (1978) (3)
The Gene Wars: Science, Politics, and the Human Genome (1996) (2)
9. Myth and Mystification Th e Science of Race and IQ (2011) (2)
The Hope, Hype, & Reality of Genetic Engineering: Remarkable Stories from Agriculture, Industry, Medicine, and the Environment.ByJohn C Avise.Oxford and New York: Oxford University Press. $35.00. xiii + 242 p; ill.; index. ISBN: 0–19–516950–6. 2004. (2004) (2)
Disguised Academic Plagiarism. A typology and case studies for researchers and editors. Research ethics forum 8 (2020) (2)
Glyphosate Toxicology (2019) (2)
Three food safety issues: life cycles of technical controversies and the social selection of risk (1995) (2)
12. Race, Genetics, and the Regulatory Need for Race Impact Assessments (2011) (2)
Crossing the Germline Barrier: The Three Genome Baby (2015) (2)
Science on trial: conflicts of interest jeopardize scientific integrity and public health. (2003) (2)
The Moral Education of Journal Editors. (2010) (2)
Financial interests of authors in scientific journals: editorial practices and author disclosures (1996) (2)
Introduction: How Science Embraced the Racialization of Human Populations (2011) (2)
A Neoliberal Economics of Science (2011) (2)
The business of research. (1972) (2)
When science falls from grace (2005) (2)
Controlling risk in biotech (1989) (2)
Gene therapy: what has been achieved after 25 years? (2005) (1)
Commentary on “the politics of certainty” (C. A. Rubino) (2000) (1)
The Multiple-World thought Experiment and Absolute Space (1972) (1)
Patents for life forms sui generic: some new questions for science, law and society (1981) (1)
Pure Science and Impure Scientists: Dilemmas for Public Policy (1984) (1)
Understanding DNA Ancestry (2021) (1)
Science Perverted: Can It Happen Here? (1983) (1)
Organizations, Uncertainties and Risk. (1994) (1)
Academics in Biotechnology (1984) (1)
Patenting life: social and ethical issues. (1980) (1)
Commentary: "On the hazards of whistleblowers and on some problems of young biomedical scientists in our time. (1995) (1)
Plastics in Our Diet (2008) (1)
BiDil: alive and kicking – Author' reply (2012) (1)
Testing Pesticides in Humans (2017) (1)
Genetic causation: a cross disciplinary inquiry. (2013) (1)
Beware of gifts that come at too great a cost (2011) (1)
Response to Editorial by Leonard E. Post (1994) (1)
Agbio benefits and pitfalls (1993) (1)
Preface: Special Issue on Stem Cells (2012) (0)
Why is this Cell Different from Other Cells (2015) (0)
Patients for life forms sui generis: some new questions for science, law and society. (1981) (0)
Glyphosate-Based Herbicides and Public Health: Making Sense of the Science (2021) (0)
Ethical issues-reply (1995) (0)
DIALOGUE 3. THE PRESIDENT’S STEM CELLS (2015) (0)
My Personalized Beta Cells for Diabetes (2015) (0)
The University: Marketing Theories, Not Toothpaste (1982) (0)
DIALOGUE 23. EMBRYOS WITHOUT OVARIES (2015) (0)
BINGHAM ET AL. RESPOND (2005) (0)
DIALOGUE 21. FEMINISM AND THE COMMERCIALIZATION OF HUMAN EGGS/EMBRYOS (2015) (0)
Stem Cell Tourism (2015) (0)
Attitudes and behavior of privately-funded biomedical scientists. (2009) (0)
Biotechnology Regulation (1995) (0)
2. Natural Selection, the Human Genome, and the Idea of Race (2011) (0)
Part I. DNA in Law Enforcement: History, Applications, and Expansion (2010) (0)
Biologists under control (1986) (0)
The Precautionary Approach: As Researchers Painstakingly Explore the Exact Mechanism of Endocrine Disruption, We Should Consider Suspect Chemicals Guilty until Proven Innocent (1998) (0)
Annotated Table of Contents (2015) (0)
Capitalizing [on] Race in Drug Development (2014) (0)
The President’s Stem Cells (2015) (0)
Feminism and the Commercialization of Human Eggs/Embryos (2015) (0)
Recoding Nature: Critical Perspectives on Genetic Engineering.Edited byRichard Hindmarshand, Geoffrey Lawrence; Foreword by, Mae‐Wan Ho.Sydney (Australia): University of New South Wales Press; distributed by University of Washington Press, Seattle (Washington). $26.95 (paper). 246 p; ill.; index. IS (2005) (0)
Reversing Macular Degeneration (2015) (0)
Sociology (1997) (0)
Commentary on Ethics and Community-Based Research: Responsibility, Precaution, and Transparency (2012) (0)
Book Review of "Bioethics in Action" Cambridge University Press. Review of Bioethics in Action edited by Françoise Baylis and Alice Dreger . Cambridge, UK: Cambridge University Press, 2019, paper, pp. vii, 177. (2021) (0)
The Rhetoric of Scientific RevolutionThe Human Genome ProjectBiotechnics and Society (1992) (0)
Appendix: A Comparison of DNA Databases in Six Nations (2010) (0)
Reconciling science with social justice (2003) (0)
Redesigning evolution? (1999) (0)
The Institutional Biosafety Committee chairperson's meeting. Procedures and operations. (1981) (0)
DIALOGUE 17. HERE COMES THE EGG MAN: OOCYTES & EMBRYOS.ORG (2015) (0)
Gene Splicing Enters the Environment: The Socio-Historical Context of the Debate over Deliberate Release (2019) (0)
Responses & Reconsiderations (1983) (0)
DIALOGUE 25. A CLINICAL TRIAL FOR PARALYSIS TREATMENT (2015) (0)
An experiment in environmental education for citizen advocates (1978) (0)
Science, Biopolitics and Risk: Margins of Uncertainty (1989) (0)
Science in the Sunshine: Transparency of Financial Conflicts of Interest (2010) (0)
Thanks to Reviewers and Sources of Submissions (2017) (0)
Daubert's menace. Authos' reply (2006) (0)
Agricultural Bioethics: Implications of Agricultural Biotechnology . 1990. Edited by Steven M. Gendel, A. David Kline, D. Michael Warren, and Faye Yates. Iowa State University Press, Ames, Iowa, xxiv, 357 pp. $34.95, cloth. (1991) (0)
When Money Talks and Science Listens (2004) (0)
Patenting Human Embryonic Stem Cells is Immoral and Illegal (In Europe) (2015) (0)
DIALOGUE 16. MY EMBRYO IS AUCTIONED ON THE INTERNET (2015) (0)
Techno farming (1991) (0)
Advancing Science in the Service of Humanity Professionalism and Ethical Safeguards (2016) (0)
Academe (2020) (0)
DIALOGUE 10. REVERSING MACULAR DEGENERATION (2015) (0)
Chapter 22: Philosophy of Biotechnology (2006) (0)
Book review of "Bioethics in Action" Cambridge University Press Review of bioethics in action , edited by Françoise Baylis and Alice Dreger , Cambridge, UK, Cambridge University Press, 2019, paper, vii, 177 pp., $29.99 (paperback), ISBN 978-1-107-54393-5. (2021) (0)
Daniel Callahan and health's price. (2004) (0)
Here Comes the Egg Man (2015) (0)
Editorial (2001) (0)
Erratum: When science falls from grace (2005) (0)
Looks like an independently refereed journal? Don't be too sure (2009) (0)
DIALOGUE 18. HUMAN-ANIMAL CHIMERAS AND HYBRIDS (2015) (0)
Eureka! New Ideas in Cell Biology (1999) (0)
DIALOGUE 9. REPAIRING BRAIN CELLS IN STROKE VICTIMS (2015) (0)
Help, Harm and Human Subjects (2010) (0)
DIALOGUE 5. THE MORAL STATUS OF EMBRYOS (2015) (0)
Embryos without Ovaries (2015) (0)
DIALOGUE 20. SOCIAL MEDIA MEET SCIENCE HYPE (2015) (0)
Conclusion Toward a Remedy for the Social Consequences of Racial Myths (2011) (0)
My Embryo is Auctioned on the Internet (2015) (0)
Book Review Research Misconduct: Issues, implications, and strategies (Contemporary Studies in Information Management, Policy, and Services.) Edited by Ellen Altman and Peter Hernon. 206 pp. Greenwich, Conn., Ablex, 1998. $73.25. 1-56750-340-3 (1998) (0)
Nancy Langston.Toxic Bodies: Hormone Disruptors and the Legacy of DES. xiv + 233 pp., illus., bibl., index. New Haven, Conn./London: Yale University Press, 2010. $30 (cloth). (2011) (0)
Part II. Comparative Systems: Forensic DNA in Five Nations (2010) (0)
Was My Birth Embryo Me (2015) (0)
Biotechnology in our lives : what modern genetics can tell you about assisted reproduction, human behavior personalized medicine, and much more (2013) (0)
Introduction: Evolving Narratives of Genetic Explanation across Disciplines (2012) (0)
Review of Three Books on Science: Trust, Corporate Influence, and Militarization (2021) (0)
DIALOGUE 4. THE DICKEY-WICKER ENIGMA (2015) (0)
AAAS Forum on Cloning (1997) (0)
Commentary: Corporate philanthropy and conflicts of interest in public health (2013) (0)
Harnessing Stem Cells for Regenerative Medicine (2015) (0)
Local monitoring of biotechnology: the second wave of recombinant DNA laws. (1982) (0)
Biotechnology in Our Lives (2013) (0)
Thanks to reviewers (2023) (0)
DIALOGUE 2. WHY IS THIS CELL DIFFERENT FROM OTHER CELLS (2015) (0)
DIALOGUE 24. HOW MY CELLS BECAME DRUGS (2015) (0)
The Great Betrayal: Fraud in Science Horace Freeland Judson (2005) (0)
Beyond the Issue of Safety (2000) (0)
DIALOGUE 11. MY STEM CELLS, MY CANCER (2015) (0)
Creating Good from Immoral Acts (2015) (0)
Roundup litigation discovery documents: implications for public health and journal ethics (2018) (0)
Playing God?: Human Genetic Engineering and the Rationalization of Public Bioethical Debate.Morality and Society Series. ByJohn H Evans.Chicago (Illinois): University of Chicago Press. $54.00 (hardcover); $20.00 (paper). viii + 304 p; ill.; index. ISBN: 0–226–22261–6 (hc); 0–226–22262–4 (pb). 2002. (2003) (0)
Social Media Meet Science Hype (2015) (0)
Rational Risk Assessment (1993) (0)
AAAS Forum on Cloning: June 25, 1997 (1997) (0)
DIALOGUE 15. PATENTING HUMAN EMBRYONIC STEM CELLS IS IMMORAL AND ILLEGAL (IN EUROPE) (2015) (0)
Alternatives to Regulation by Michael S. Baram (1982) (0)
The Dickey-Wicker Enigma (2015) (0)
DIALOGUE 22. WAS MY BIRTH EMBRYO ME (2015) (0)
DIALOGUE 6. CREATING GOOD FROM IMMORAL ACTS (2015) (0)
On deductive non-nomological explanation (1976) (0)
Disguised Academic PlagiarismResearch Ethics Forum 8. by M.V. Dougherty , Springer, 2020. 158pp. Hardcover, $59.99 ISBN 978-3-030-46710-4. (2020) (0)
DIALOGUE 19. STEM CELL TOURISM (2015) (0)
DIALOGUE 12. REPROGRAMMING CELLS (2015) (0)
Science and Politics in Transition: Making Sense of Biotechnology Policy (1987) (0)
For the record. Author's reply (2002) (0)
DIALOGUE 1. HOPE (2015) (0)
Academic freedom and tenure: Bastyr university (Washington)' (2007) (0)
IS FLUORIDE REALLY ALL THAT SAFE?: The Fluoride Deception, by Christopher Bryson, Seven Stories Press, 2004,374 pages, $24.95 (ISBN 1-58322-526-9) (2004) (0)
Race-Ing Patents/Patenting Race (2014) (0)
DIALOGUE 13. MY PERSONALIZED DISEASE CELLS (2015) (0)
Part III. Critical Perspectives: Balancing Personal Liberty, Social Equity, and Security (2010) (0)
How My Cells Became Drugs (2015) (0)
Commentary: Corporate philanthropy and conflicts of interest in public health (2012) (0)
DIALOGUE 14. TO CLONE OR NOT TO CLONE: THAT IS THE QUESTION (2015) (0)
The Birth of BiDil (2014) (0)
Science, Society, and the Expanding Boundaries of Moral Discourse (1995) (0)
Book review of "Bioethics in Action" Cambridge University Press Review of bioethics in action, edited by Françoise Baylis and Alice Dreger, Cambridge, UK, Cambridge University Press, 2019, paper, vii, 177 pp., $29.99 (paperback), ISBN 978-1-107-54393-5. (2021) (0)
Revising the Revision of Genetically Modified Plant Oversight (1992) (0)
Acknowledgement to reviewers (2010) (0)
Statistical Mischief and Racial Frames for Drug Development and Marketing (2014) (0)
Editorial (2009) (0)
Repairing Brain Cells in Stroke Victims (2015) (0)
DIALOGUE 8. MY PERSONALIZED BETA CELLS FOR DIABETES (2015) (0)
To Clone or not to Clone (2015) (0)
Uphold the nuclear weapons test moratorium (2020) (0)
The Moral Status of Embryos (2015) (0)
A Clinical Trial for Paralysis Treatment (2015) (0)
DIALOGUE 7. CIRCUMVENTING EMBRYOCIDE (2015) (0)
My Stem Cells, My Cancer (2015) (0)
For the record (2002) (0)
Human-Animal Chimeras and Hybrids (2015) (0)
Gene mapping: Using law and ethics as guides: edited by George G. Annas and Sherman Elias. Oxford University Press, New York, 1992. xxii; 291 pp., $39.95 (1994) (0)
My Personalized Disease Cells (2015) (0)
Book Review (2008) (0)
IS FLUORIDE REALLY ALL THAT SAFE (2004) (0)
Thomas R. DeGregori.Origins of the Organic Agriculture Debate. xviii + 211 pp., refs., index. Ames: Iowa State Press, 2004. $56.99 (cloth). (2006) (0)
Carrying the Baconian Torch (1988) (0)
Core of controversy over biohazards (1979) (0)
Preface: CRISPR Technology, Gene Editing (2015) (0)
Book Review:The Gene Business. Who Should Control Biotechnology? Edward Yoxen (1985) (0)

This paper list is powered by the following services:

Other Resources About Sheldon Krimsky

en.wikipedia.org

What Schools Are Affiliated With Sheldon Krimsky?

Sheldon Krimsky is affiliated with the following schools: